Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2024 Mar 28

PMID 38543320

Authors

Chen Ankri

Oren Hershkovitz

Liat Hershkovitz

Meital Brami

Ronnie Levy

Hadar Sarig

Einat Souli

Barak Reicher

Veronique Amor-Baroukh

Dror Mevorach

Abraham Nyska

Affiliations

Soon will be listed here.

Abstract

Apoptotic cells possess immunomodulatory effects that can be utilized to treat imbalanced immune conditions. Information on the preclinical safety of such treatment is sparse. In this study, the safety of apoptotic cells (Allocetra-OTS) was assessed in a GLP toxicological study on Sprague Dawley rats. Three doses of Allocetra-OTS or vehicle were administered intravenously (IV) for 3 consecutive days. Animals in the main study were sacrificed on day 4, while animals from the recovery groups were kept for 14 or 28 days. Allocetra-OTS was well tolerated, and no adverse effects were observed in terms of body weight, clinical signs, food consumption, or ophthalmologic observation. Thus, the No Observed Adverse Effect Level (NOAEL) dose was determined as the highest dose administered. An observed elevation in immune cells was suspected to be due to Allocetra-OTS, similarly to other clinical chemistry parameters; however, it was resolved in the recovery phases. Splenomegaly and dose-related extramedullary hematopoiesis (EMH) in the red pulp were observed, with no adverse events, and were considered to be a normal and expected reaction following the IV administration of cell-based therapies. In conclusion, under the conditions of this study, Allocetra-OTS was concluded to be safe, further supporting its potential candidacy for clinical studies.

References

Shin S, Moon S, Park D, Park J, Lee C . Apoptotic cell clearance in the tumor microenvironment: a potential cancer therapeutic target. Arch Pharm Res. 2019; 42(8):658-671. DOI: 10.1007/s12272-019-01169-2. View

Trahtemberg U, Mevorach D . Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells. Front Immunol. 2017; 8:1356. PMC: 5661053. DOI: 10.3389/fimmu.2017.01356. View

Elmore S, Dixon D, Hailey J, Harada T, Herbert R, Maronpot R . Recommendations from the INHAND Apoptosis/Necrosis Working Group. Toxicol Pathol. 2016; 44(2):173-88. PMC: 4785073. DOI: 10.1177/0192623315625859. View

Engelhardt J, Dorato M . Perspective on Adversity in Toxicology Evaluations. Toxicol Pathol. 2020; 49(2):408-410. DOI: 10.1177/0192623320941791. View

Lichtenauer M, Mildner M, Baumgartner A, Hasun M, Werba G, Beer L . Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol. 2011; 106(4):645-55. PMC: 3105227. DOI: 10.1007/s00395-011-0173-0. View

Delbruck C, Gambichler T, Susok L, Peinemann F . Extracorporeal photopheresis for systemic sclerosis: A meta-analysis of randomized clinical trials. Dermatol Ther. 2022; 35(7):e15530. DOI: 10.1111/dth.15530. View

Kumari D, Nair N, Bedwal R . Morphological changes in spleen after dietary zinc deficiency and supplementation in Wistar rats. Pharmacol Rep. 2019; 71(2):206-217. DOI: 10.1016/j.pharep.2018.10.017. View

Huynh M, Fadok V, Henson P . Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest. 2002; 109(1):41-50. PMC: 150814. DOI: 10.1172/JCI11638. View

Iezzi G, Scheidegger D, Lanzavecchia A . Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med. 2001; 193(8):987-93. PMC: 2193404. DOI: 10.1084/jem.193.8.987. View

10.

Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O . Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med. 2002; 196(12):1553-61. PMC: 2196062. DOI: 10.1084/jem.20020263. View

11.

Zhang H, Li Y, Liu X, Chen B, Yao G, Peng Y . Extramedullary hematopoiesis: A report of two cases. Exp Ther Med. 2017; 12(6):3859-3862. PMC: 5228087. DOI: 10.3892/etm.2016.3855. View

12.

Elliott M, Ravichandran K . The Dynamics of Apoptotic Cell Clearance. Dev Cell. 2016; 38(2):147-60. PMC: 4966906. DOI: 10.1016/j.devcel.2016.06.029. View

13.

Gandelman J, Song D, Chen H, Engelhardt B, Chen Y, Clark W . A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells. Biol Blood Marrow Transplant. 2018; 24(12):2373-2380. DOI: 10.1016/j.bbmt.2018.06.035. View

14.

An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X . Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019; 33(11):12515-12527. PMC: 6902677. DOI: 10.1096/fj.201802805RR. View

15.

Patel S, Thiagarajan R, Willerson J, Yeh E . Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation. 1998; 97(1):75-81. DOI: 10.1161/01.cir.97.1.75. View

16.

Kleinclauss F, Perruche S, Masson E, De Carvalho Bittencourt M, Biichle S, Remy-Martin J . Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ. 2005; 13(1):41-52. PMC: 3448559. DOI: 10.1038/sj.cdd.4401699. View

17.

Das A, Ganesh K, Khanna S, Sen C, Roy S . Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol. 2014; 192(3):1120-9. PMC: 4358325. DOI: 10.4049/jimmunol.1300613. View

18.

Krispin A, Bledi Y, Atallah M, Trahtemberg U, Verbovetski I, Nahari E . Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood. 2006; 108(10):3580-9. DOI: 10.1182/blood-2006-03-013334. View

19.

van Heerden P, Abutbul A, Sviri S, Zlotnick E, Nama A, Zimro S . Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis- A Phase Ib Clinical Trial. Front Immunol. 2021; 12:718191. PMC: 8515139. DOI: 10.3389/fimmu.2021.718191. View

20.

Perruche S, Saas P, Chen W . Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?. Arthritis Res Ther. 2009; 11(4):R104. PMC: 2745779. DOI: 10.1186/ar2750. View